IBDEI2HA ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,39575,2)
;;=^321978
;;^UTILITY(U,$J,358.3,39576,0)
;;=D63.8^^152^2000^22
;;^UTILITY(U,$J,358.3,39576,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39576,1,3,0)
;;=3^Anemia in Chronic Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,39576,1,4,0)
;;=4^D63.8
;;^UTILITY(U,$J,358.3,39576,2)
;;=^5002343
;;^UTILITY(U,$J,358.3,39577,0)
;;=C22.3^^152^2000^27
;;^UTILITY(U,$J,358.3,39577,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39577,1,3,0)
;;=3^Angiosarcoma of Liver
;;^UTILITY(U,$J,358.3,39577,1,4,0)
;;=4^C22.3
;;^UTILITY(U,$J,358.3,39577,2)
;;=^5000936
;;^UTILITY(U,$J,358.3,39578,0)
;;=D61.9^^152^2000^28
;;^UTILITY(U,$J,358.3,39578,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39578,1,3,0)
;;=3^Aplastic Anemia,Unspec
;;^UTILITY(U,$J,358.3,39578,1,4,0)
;;=4^D61.9
;;^UTILITY(U,$J,358.3,39578,2)
;;=^5002342
;;^UTILITY(U,$J,358.3,39579,0)
;;=D56.1^^152^2000^30
;;^UTILITY(U,$J,358.3,39579,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39579,1,3,0)
;;=3^Beta Thalassemia
;;^UTILITY(U,$J,358.3,39579,1,4,0)
;;=4^D56.1
;;^UTILITY(U,$J,358.3,39579,2)
;;=^340495
;;^UTILITY(U,$J,358.3,39580,0)
;;=C83.79^^152^2000^32
;;^UTILITY(U,$J,358.3,39580,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39580,1,3,0)
;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,39580,1,4,0)
;;=4^C83.79
;;^UTILITY(U,$J,358.3,39580,2)
;;=^5001600
;;^UTILITY(U,$J,358.3,39581,0)
;;=C83.70^^152^2000^33
;;^UTILITY(U,$J,358.3,39581,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39581,1,3,0)
;;=3^Burkitt Lymphoma,Unspec Site
;;^UTILITY(U,$J,358.3,39581,1,4,0)
;;=4^C83.70
;;^UTILITY(U,$J,358.3,39581,2)
;;=^5001591
;;^UTILITY(U,$J,358.3,39582,0)
;;=D09.0^^152^2000^40
;;^UTILITY(U,$J,358.3,39582,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39582,1,3,0)
;;=3^Carcinoma in Situ of Bladder
;;^UTILITY(U,$J,358.3,39582,1,4,0)
;;=4^D09.0
;;^UTILITY(U,$J,358.3,39582,2)
;;=^267742
;;^UTILITY(U,$J,358.3,39583,0)
;;=D06.9^^152^2000^41
;;^UTILITY(U,$J,358.3,39583,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39583,1,3,0)
;;=3^Carcinoma in Situ of Cervix
;;^UTILITY(U,$J,358.3,39583,1,4,0)
;;=4^D06.9
;;^UTILITY(U,$J,358.3,39583,2)
;;=^5001941
;;^UTILITY(U,$J,358.3,39584,0)
;;=D06.0^^152^2000^43
;;^UTILITY(U,$J,358.3,39584,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39584,1,3,0)
;;=3^Carcinoma in Situ of Endocervix
;;^UTILITY(U,$J,358.3,39584,1,4,0)
;;=4^D06.0
;;^UTILITY(U,$J,358.3,39584,2)
;;=^5001938
;;^UTILITY(U,$J,358.3,39585,0)
;;=D06.1^^152^2000^44
;;^UTILITY(U,$J,358.3,39585,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39585,1,3,0)
;;=3^Carcinoma in Situ of Exocervix
;;^UTILITY(U,$J,358.3,39585,1,4,0)
;;=4^D06.1
;;^UTILITY(U,$J,358.3,39585,2)
;;=^5001939
;;^UTILITY(U,$J,358.3,39586,0)
;;=D06.7^^152^2000^42
;;^UTILITY(U,$J,358.3,39586,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39586,1,3,0)
;;=3^Carcinoma in Situ of Cervix,Other Parts
;;^UTILITY(U,$J,358.3,39586,1,4,0)
;;=4^D06.7
;;^UTILITY(U,$J,358.3,39586,2)
;;=^5001940
;;^UTILITY(U,$J,358.3,39587,0)
;;=D04.9^^152^2000^45
;;^UTILITY(U,$J,358.3,39587,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39587,1,3,0)
;;=3^Carcinoma in Situ of Skin
;;^UTILITY(U,$J,358.3,39587,1,4,0)
;;=4^D04.9
;;^UTILITY(U,$J,358.3,39587,2)
;;=^5001925
;;^UTILITY(U,$J,358.3,39588,0)
;;=C91.11^^152^2000^48
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2HA 3757 printed Dec 13, 2024@02:28:43 Page 2
IBDEI2HA ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,39575,2)
+2 ;;=^321978
+3 ;;^UTILITY(U,$J,358.3,39576,0)
+4 ;;=D63.8^^152^2000^22
+5 ;;^UTILITY(U,$J,358.3,39576,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,39576,1,3,0)
+8 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
+9 ;;^UTILITY(U,$J,358.3,39576,1,4,0)
+10 ;;=4^D63.8
+11 ;;^UTILITY(U,$J,358.3,39576,2)
+12 ;;=^5002343
+13 ;;^UTILITY(U,$J,358.3,39577,0)
+14 ;;=C22.3^^152^2000^27
+15 ;;^UTILITY(U,$J,358.3,39577,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,39577,1,3,0)
+18 ;;=3^Angiosarcoma of Liver
+19 ;;^UTILITY(U,$J,358.3,39577,1,4,0)
+20 ;;=4^C22.3
+21 ;;^UTILITY(U,$J,358.3,39577,2)
+22 ;;=^5000936
+23 ;;^UTILITY(U,$J,358.3,39578,0)
+24 ;;=D61.9^^152^2000^28
+25 ;;^UTILITY(U,$J,358.3,39578,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,39578,1,3,0)
+28 ;;=3^Aplastic Anemia,Unspec
+29 ;;^UTILITY(U,$J,358.3,39578,1,4,0)
+30 ;;=4^D61.9
+31 ;;^UTILITY(U,$J,358.3,39578,2)
+32 ;;=^5002342
+33 ;;^UTILITY(U,$J,358.3,39579,0)
+34 ;;=D56.1^^152^2000^30
+35 ;;^UTILITY(U,$J,358.3,39579,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,39579,1,3,0)
+38 ;;=3^Beta Thalassemia
+39 ;;^UTILITY(U,$J,358.3,39579,1,4,0)
+40 ;;=4^D56.1
+41 ;;^UTILITY(U,$J,358.3,39579,2)
+42 ;;=^340495
+43 ;;^UTILITY(U,$J,358.3,39580,0)
+44 ;;=C83.79^^152^2000^32
+45 ;;^UTILITY(U,$J,358.3,39580,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,39580,1,3,0)
+48 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
+49 ;;^UTILITY(U,$J,358.3,39580,1,4,0)
+50 ;;=4^C83.79
+51 ;;^UTILITY(U,$J,358.3,39580,2)
+52 ;;=^5001600
+53 ;;^UTILITY(U,$J,358.3,39581,0)
+54 ;;=C83.70^^152^2000^33
+55 ;;^UTILITY(U,$J,358.3,39581,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,39581,1,3,0)
+58 ;;=3^Burkitt Lymphoma,Unspec Site
+59 ;;^UTILITY(U,$J,358.3,39581,1,4,0)
+60 ;;=4^C83.70
+61 ;;^UTILITY(U,$J,358.3,39581,2)
+62 ;;=^5001591
+63 ;;^UTILITY(U,$J,358.3,39582,0)
+64 ;;=D09.0^^152^2000^40
+65 ;;^UTILITY(U,$J,358.3,39582,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,39582,1,3,0)
+68 ;;=3^Carcinoma in Situ of Bladder
+69 ;;^UTILITY(U,$J,358.3,39582,1,4,0)
+70 ;;=4^D09.0
+71 ;;^UTILITY(U,$J,358.3,39582,2)
+72 ;;=^267742
+73 ;;^UTILITY(U,$J,358.3,39583,0)
+74 ;;=D06.9^^152^2000^41
+75 ;;^UTILITY(U,$J,358.3,39583,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,39583,1,3,0)
+78 ;;=3^Carcinoma in Situ of Cervix
+79 ;;^UTILITY(U,$J,358.3,39583,1,4,0)
+80 ;;=4^D06.9
+81 ;;^UTILITY(U,$J,358.3,39583,2)
+82 ;;=^5001941
+83 ;;^UTILITY(U,$J,358.3,39584,0)
+84 ;;=D06.0^^152^2000^43
+85 ;;^UTILITY(U,$J,358.3,39584,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,39584,1,3,0)
+88 ;;=3^Carcinoma in Situ of Endocervix
+89 ;;^UTILITY(U,$J,358.3,39584,1,4,0)
+90 ;;=4^D06.0
+91 ;;^UTILITY(U,$J,358.3,39584,2)
+92 ;;=^5001938
+93 ;;^UTILITY(U,$J,358.3,39585,0)
+94 ;;=D06.1^^152^2000^44
+95 ;;^UTILITY(U,$J,358.3,39585,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,39585,1,3,0)
+98 ;;=3^Carcinoma in Situ of Exocervix
+99 ;;^UTILITY(U,$J,358.3,39585,1,4,0)
+100 ;;=4^D06.1
+101 ;;^UTILITY(U,$J,358.3,39585,2)
+102 ;;=^5001939
+103 ;;^UTILITY(U,$J,358.3,39586,0)
+104 ;;=D06.7^^152^2000^42
+105 ;;^UTILITY(U,$J,358.3,39586,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,39586,1,3,0)
+108 ;;=3^Carcinoma in Situ of Cervix,Other Parts
+109 ;;^UTILITY(U,$J,358.3,39586,1,4,0)
+110 ;;=4^D06.7
+111 ;;^UTILITY(U,$J,358.3,39586,2)
+112 ;;=^5001940
+113 ;;^UTILITY(U,$J,358.3,39587,0)
+114 ;;=D04.9^^152^2000^45
+115 ;;^UTILITY(U,$J,358.3,39587,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,39587,1,3,0)
+118 ;;=3^Carcinoma in Situ of Skin
+119 ;;^UTILITY(U,$J,358.3,39587,1,4,0)
+120 ;;=4^D04.9
+121 ;;^UTILITY(U,$J,358.3,39587,2)
+122 ;;=^5001925
+123 ;;^UTILITY(U,$J,358.3,39588,0)
+124 ;;=C91.11^^152^2000^48
